(Q40305032)

19 September 2017

title

Assessment of risk factors for Korean children with Kawasaki disease (English)

1 reference

19 September 2017

13

In-Sook Park

1 reference

19 September 2017

Jae-Jung Kim

1

1 reference

19 September 2017

Young Mi Hong

2

1 reference

19 September 2017

Sin Weon Yun

3

1 reference

19 September 2017

Myung Ki Han

4

1 reference

19 September 2017

Kyung-Yil Lee

5

1 reference

19 September 2017

Min Seob Song

6

1 reference

19 September 2017

Hyoung-Doo Lee

7

1 reference

19 September 2017

Dong Soo Kim

8

1 reference

19 September 2017

Sejung Sohn

9

1 reference

19 September 2017

Kee-Soo Ha

10

1 reference

19 September 2017

Soo-Jong Hong

11

1 reference

19 September 2017

Kwi-Joo Kim

12

1 reference

19 September 2017

Gi Young Jang

14

1 reference

19 September 2017

Jong-Keuk Lee

15

1 reference

19 September 2017

Korean Kawasaki Disease Genetics Consortium

16

1 reference

19 September 2017

publication date

22 November 2011

1 reference

19 September 2017

1 reference

19 September 2017

volume

33

1 reference

19 September 2017

issue

4

1 reference

19 September 2017

page(s)

513-520

1 reference

Risk factors for nonresponse to therapy in Kawasaki disease

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00246-011-0143-1

A predictive instrument for coronary artery aneurysms in Kawasaki disease. US Multicenter Kawasaki Disease Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00246-011-0143-1

Sequelae of Kawasaki disease in adolescents and young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00246-011-0143-1

Guidelines for long-term management of patients with Kawasaki disease. Report from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00246-011-0143-1

Intravenous γ-Globulin Treatment in Kawasaki Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00246-011-0143-1

Clinical relevance of the risk factors for coronary artery inflammation in Kawasaki disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00246-011-0143-1

Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00246-011-0143-1

Kawasaki disease: review of risk factors for coronary aneurysms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00246-011-0143-1

Serum albumin level predicts initial intravenous immunoglobulin treatment failure in Kawasaki disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00246-011-0143-1

Predictors of coronary artery lesions after intravenous gamma-globulin treatment in Kawasaki disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00246-011-0143-1

The Pellino family: IRAK E3 ligases with emerging roles in innate immune signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00246-011-0143-1

21 January 2018

TLR signaling pathways

1 reference

https://api.crossref.org/works/10.1007%2FS00246-011-0143-1

Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00246-011-0143-1

Prognostic impact of vascular leakage in acute Kawasaki disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00246-011-0143-1

Rapid development of life-threatening complete atrioventricular block in Kearns-Sayre syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00246-011-0143-1

Incomplete Kawasaki disease in patients younger than 1 year of age: a possible inherent risk factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00246-011-0143-1

The Treatment of Kawasaki Syndrome with Intravenous Gamma Globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00246-011-0143-1

The prevention of coronary artery aneurysm in Kawasaki disease: a meta-analysis on the efficacy of aspirin and immunoglobulin treatment.

21 January 2018

1 reference

12 December 2020

High-dose intravenous gammaglobulin for Kawasaki disease

1 reference

12 December 2020

Systemic production of vascular endothelial growth factor and fms-like tyrosine kinase-1 receptor in acute Kawasaki disease

1 reference

12 December 2020

TLR2 and MyD88 contribute to Lactobacillus casei extract-induced focal coronary arteritis in a mouse model of Kawasaki disease

1 reference

12 December 2020

Coronary artery dimensions may be misclassified as normal in Kawasaki disease

1 reference

12 December 2020

1 reference

12 December 2020

A genome-wide association study identifies novel and functionally related susceptibility Loci for Kawasaki disease

1 reference

12 December 2020

Coronary risks after high-dose gamma-globulin in children with Kawasaki disease

1 reference

12 December 2020

Intravenous gamma-globulin treatment and retreatment in Kawasaki disease. US/Canadian Kawasaki Syndrome Study Group

1 reference

12 December 2020

Intravenous gamma-globulin treatment in Kawasaki disease

1 reference

12 December 2020

Prevalence of coronary artery abnormality in incomplete Kawasaki disease

1 reference

12 December 2020

Diagnosis, treatment, and long-term management of Kawasaki disease

1 reference

12 December 2020

A genome-wide association analysis reveals 1p31 and 2p13.3 as susceptibility loci for Kawasaki disease

1 reference

12 December 2020

Animal models of vasculitis. Lessons we can learn to improve our understanding of Kawasaki disease.

1 reference

12 December 2020

Adult coronary artery disease probably due to childhood Kawasaki disease

1 reference

12 December 2020

Immunoglobulin failure and retreatment in Kawasaki disease

1 reference

12 December 2020

Plasma clusterin levels in predicting the occurrence of coronary artery lesions in patients with Kawasaki disease

1 reference

12 December 2020

10.1007/S00246-011-0143-1

Identifiers

DOI

1 reference

Dimensions Publication ID

19 September 2017

1009346053

0 references

1 reference